Jason Assad

Jason Assad has a diverse work experience in corporate communications, investor relations, and strategic advisory services. Their most recent role was as the Director of Corporate Communications at TeraWulf. Prior to that, they worked as a Communications Strategist at Coya Therapeutics, Gain Therapeutics, Processa Pharmaceuticals, and Hoth Therapeutics. Jason has also held positions as the Head of Corporate Communications at Crown Electrokinetics, 180 Life Sciences, and Unrivaled Brands. In addition, they have experience as the President of C&H Capital Inc., where they provided seed financing and strategic advisory services to small-cap companies. Jason began their career as the Head of Corporate Communications at Amergent Hospitality Group, Inc. Overall, Jason has a strong background in communication and strategic management in various industries.

Jason Assad attended The University of Georgia from 1989 to 1993, where they obtained a Bachelor's Degree in Public Relations.